Published in:
01-08-2015 | Case Report
Atypical teratoid rhabdoid tumor: long-term survival after chemoradiotherapy
Authors:
Vivek Verma, Catrina P. Johnson, Nathan R. Bennion, Abhijeet R. Bhirud, Sicong Li, Rodney D. McComb, Chi Lin
Published in:
Child's Nervous System
|
Issue 8/2015
Login to get access
Abstract
Purpose
Atypical teratoid rhabdoid tumors (ATRTs) arise from the central nervous system largely in the pediatric population. They portend a very poor prognosis with few long-term survivors. We describe a series of five cases at our institution.
Methods
We conducted a retrospective chart review and clinical follow-up.
Results
Three patients underwent chemoradiation after surgical resection; the two patients whose caretakers declined this therapy passed away soon after diagnosis. Chemoradiation included intravenous and intrathecal chemotherapy as well as intensity-modulated radiotherapy after resection. Of the patients receiving chemoradiation, two patients had infratentorial tumors, two had gross residual tumor after resection, and two were under the age of 3 years. The three patients receiving trimodality therapy remain clinically and symptomatically disease-free with follow-up times of 44, 46, and 55 months. Two of the patients have mild neuropsychiatric sequelae after therapy.
Conclusions
Long-term, high-volume trials of ATRT are currently not published. We offer experience in successful long-term survival of this tumor treated with chemoradiotherapy.